# Maximon

Maximon is a Private Equity based in Zug, Switzerland.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Zug, Switzerland
- **Region:** Europe
- **Address:** Zug, Switzerland
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** www.maximon.com
- **LinkedIn:** https://www.linkedin.com/company/maximon

## Regulatory record

- **Reports private funds:** No

## About

Maximon empowers entrepreneurs to build impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions. "longevity"

## Sectors

- Longevity

## People

- Dr. Tobias Reichmuth — Founding Partner
- Marc P. Bernegger — Founding Partner
- Jörg Rieker — Founding Partner
- Caroline Wagner — Founding Partner

## Questions

### How does Maximon structure its investments?

Maximon operates as a company builder, not a conventional venture capital fund. It creates new ventures internally, provides the corporate setup, seed and Series A funding of up to CHF 10 million, and embeds temporary co-founders and back-office staff from its own team. The firm retains legal and operational control within a unified legal and tax structure until exit.

### Does Maximon invest in existing startups or only build its own?

Maximon builds its own companies from scratch. The firm's model centers on developing science-based longevity concepts internally before incorporating them as new entities, rather than backing external management teams through minority equity stakes. Its website lists portfolio companies AVEA and Frieda Health as examples of ventures it constructed and operated.

### What scientific resources does Maximon provide to its portfolio companies?

Maximon offers access to an in-house scientific advisory board that includes Dr. Brian Kennedy, a researcher at the National University of Singapore, and Prof. Dr. Evelyne Yehudit Bischof, a physician-scientist. The firm also supplies study-design support and facilitates cooperation across its portfolio for shared scientific insight.

### How does Maximon source deal flow?

The firm's primary sourcing channel is its owned Longevity Investors Conference, an event that gathers researchers, founders, and investors in the longevity space. Combined with its advisory network and European research-campus relationships, the conference serves as both a proprietary origination pipeline and a brand-building platform.

### Who makes the investment decisions at Maximon?

The founding partners—Dr. Tobias Reichmuth, Marc P. Bernegger, Jörg Rieker, and Caroline Wagner—lead investment decisions. They are supported by an operating partner, a head of finance, and a lead venture builder who manage the shared-services layer each new company requires.

## Related profiles

- [Maxim Group](https://altss.com/profile/maxim-financial-advisors)
- [Maxim Partners](https://altss.com/profile/maxim-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/maximon

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology